Biomark Diagnostics Statistics

Total Valuation

CSE:BUX has a market cap or net worth of CAD 19.34 million. The enterprise value is 20.81 million.

Market Cap	19.34M
Enterprise Value	20.81M

Important Dates

The next estimated earnings date is Friday, July 25, 2025.

Earnings Date	Jul 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+709.75%
Shares Change (QoQ)	+874.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	39.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.97
EV / Sales	128.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-24.21

Financial Position

The company has a current ratio of 0.10

Current Ratio	0.10
Quick Ratio	0.10
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.73
Interest Coverage	-27.12

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-107.55%
Return on Invested Capital (ROIC)	-144.93%
Return on Capital Employed (ROCE)	297.51%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.14
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.00% in the last 52 weeks. The beta is -0.62, so CSE:BUX's price volatility has been lower than the market average.

Beta (5Y)	-0.62
52-Week Price Change	-10.00%
50-Day Moving Average	0.23
200-Day Moving Average	0.23
Relative Strength Index (RSI)	78.00
Average Volume (20 Days)	9,007

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CSE:BUX had revenue of CAD 155,029 and -1.90 million in losses. Loss per share was -0.00.

Revenue	155,029
Gross Profit	155,029
Operating Income	-1.92M
Pretax Income	-1.90M
Net Income	-1.90M
EBITDA	-1.90M
EBIT	-1.92M
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 88,583 in cash and 1.49 million in debt, giving a net cash position of -1.40 million.

Cash & Cash Equivalents	88,583
Total Debt	1.49M
Net Cash	-1.40M
Net Cash Per Share	n/a
Equity (Book Value)	-1.10M
Book Value Per Share	-0.01
Working Capital	-1.36M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -855,645 and capital expenditures -3,744, giving a free cash flow of -859,389.

Operating Cash Flow	-855,645
Capital Expenditures	-3,744
Free Cash Flow	-859,389
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,235.35%
Pretax Margin	-1,223.42%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:BUX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-709.75%
Shareholder Yield	-709.75%
Earnings Yield	-9.80%
FCF Yield	-4.44%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CSE:BUX has an Altman Z-Score of -27.36. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-27.36
Piotroski F-Score	n/a